Suppr超能文献

慢性乙型肝炎患者外周血和肝内浸润淋巴细胞的 TCR Vβ 使用情况。

TCR Vβ Usage of Peripheral Blood and Liver Infiltrating Lymphocytes in Patients with Chronic Hepatitis B.

机构信息

Affiliated Hospital of Jining Medical University, China. Clinical Laboratory.

Affiliated Hospital of Jining Medical University, China. Nursing Department.

出版信息

Ann Hepatol. 2018 Mar 1;17(2):214-222. doi: 10.5604/01.3001.0010.8636.

Abstract

INTRODUCTION

Chronic hepatitis B (CHB) is still a public health problem and its mechanism remains unclear. In this study, we detect the skewness of T cell receptor beta chain variable gene (TCR Vβ) in peripheral blood lymphocytes (PBL) and the liver infiltrating lymphocytes (LIL) of patients with CHB; and hope to provide information for further research on the pathogenic mechanism of CHB.

MATERIAL AND METHODS

Fifteen patients with CHB, ten healthy volunteers and three patients with liver cysts were recruited as the subjects. The usage of TCR Vβ of PBL and LIL were measured and compared; the associations of the TCR Vβ usage of PBL with some hematological indices, including human leukocyte antigen (HLA) alleles, percents of CD4+ and CD8+ T cells, sera levels of HBV-DNA and IFN-γ, were analyzed.

RESULTS

In PBL, Vβ12 and Vβ13.1 were the highest predominant usage genes which usage frequencies were all 46.7%; Vβ23 was the key limited usage gene (40.0%). In LIL, the mainly predominant and limited usage gene was Vβ13.1 (73.3%) and Vβ23 (46.7%), respectively. About half of the patients with CHB with HLA-DR9 or HLA-DR12 showed the predominant usage of Vβ5.2 or Vβ13.2. In patients with CHB, the percentage of CD4+ T cells was 33.41 ± 5.39 %, that of CD8+ T cells was 28.67 ± 6.77 %; the concentration of IFN-γ was 182.52 ± 44.16 pg/mL. Compared to the healthy controls, there were significant differences for these data (P < 0.05). Neither ALT nor HBV-DNA was relative to the usage of TCR Vβ.

CONCLUSIONS

PBL and LIL share the common sknewness of TCR Vβ genes, which probably relates to some hematological indices. However, the roles of such similarities and associations in the development of CHB need further study.

摘要

简介

慢性乙型肝炎(CHB)仍然是一个公共卫生问题,其发病机制尚不清楚。在本研究中,我们检测了 CHB 患者外周血淋巴细胞(PBL)和肝浸润淋巴细胞(LIL)中 T 细胞受体β链可变基因(TCR Vβ)的偏度,并希望为进一步研究 CHB 的发病机制提供信息。

材料和方法

招募了 15 名 CHB 患者、10 名健康志愿者和 3 名肝囊肿患者作为研究对象。测量和比较了 PBL 和 LIL 的 TCR Vβ 使用情况;分析了 PBL 的 TCR Vβ 使用与一些血液学指标(包括人类白细胞抗原(HLA)等位基因、CD4+和 CD8+T 细胞的百分比、HBV-DNA 和 IFN-γ 的血清水平)之间的关系。

结果

在 PBL 中,Vβ12 和 Vβ13.1 是最高的优势使用基因,其使用频率均为 46.7%;Vβ23 是关键的限制使用基因(40.0%)。在 LIL 中,主要的优势和限制使用基因分别是 Vβ13.1(73.3%)和 Vβ23(46.7%)。约一半的 HLA-DR9 或 HLA-DR12 阳性的 CHB 患者表现为 Vβ5.2 或 Vβ13.2 的优势使用。CHB 患者的 CD4+T 细胞百分比为 33.41±5.39%,CD8+T 细胞百分比为 28.67±6.77%;IFN-γ浓度为 182.52±44.16pg/mL。与健康对照组相比,这些数据均有显著差异(P<0.05)。ALT 和 HBV-DNA 均与 TCR Vβ 的使用无关。

结论

PBL 和 LIL 共享 TCR Vβ 基因的共同偏度,这可能与一些血液学指标有关。然而,CHB 发展过程中这些相似性和相关性的作用还需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验